Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / NEA Management Company, LLC
Form 13F · Q2 2026

NEA Management Company, LLC

CIK 1512848Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.6B
Reported book value
26
Positions
12
Quarters on record
Top 50
Positions

NEA Management Company, LLC — holdings

Top 26 positions of 26, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TRVI Trevi Therapeutics Inc13.2M+0.0%$247M15.5%
2MBX Mbx Biosciences Inc3.6M+0.0%$200M12.6%
3GLUE Monte Rosa Therapeutics Inc7.7M+0.0%$186M11.7%
4CELC Celcuity Inc1.7M−25.2%$179M11.3%
5SGP Spyglass Pharma Inc7.4M+0.0%$165M10.4%
6SVRA Savara Inc24.5M+0.0%$151M9.5%
7ZBIO Zenas Biopharma Inc4.0M+0.0%$102M6.4%
8COUR Coursera Inc12.9M+0.0%$73M4.6%
9AUPH Aurinia Pharmaceuticals Inc4.0M+0.0%$67M4.2%
10CRSP Crispr Therapeutics Ag1.1M+0.0%$58M3.6%
11ORIC Oric Pharmaceuticals Inc4.1M+0.0%$45M2.8%
12PHAT Phathom Pharmaceuticals Inc2.0M+0.0%$21M1.3%
13KRRO Korro Bio Inc1.3M+0.0%$17M1.1%
14XFOR X4 Pharmaceuticals, Inc.3.2M+0.0%$15M1.0%
15CSBR Champions Oncology Inc1.7M+0.0%$11M0.7%
16NKTX Nkarta Inc3.6M+0.0%$10M0.6%
17CVRX Cvrx Inc2.0M−3.5%$10M0.6%
18BDTX Black Diamond Therapeutics I4.4M+0.0%$8M0.5%
19KPTIQ Karyopharm Therapeutics Inc576,780—$6M0.4%
20IVA Inventiva Sa1.5M+0.0%$6M0.3%
21LONA Leonabio Inc464,398+0.0%$4M0.3%
22SNTI Senti Biosciences, Inc.3.8M+0.0%$4M0.3%
23MRKR Marker Therapeutics Inc1.6M+0.0%$2M0.2%
24OKUR Onkure Therapeutics Inc478,548+0.0%$2M0.1%
25IMA Imagenebio Inc50,005+0.0%$295,0300.0%
26GOSS Gossamer Bio Inc1.0M+0.0%$164,6000.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.